THE Food and Drug Administration (FDA) said it had registered AstraZeneca coronavirus vaccine made in Italy on Wednesday January 20 after the company submitted nearly 10,000 pages of documents in making this application, Thai Rath reported today (Jan. 22).
The Italian company will deliver the first lot of 50,000 doses next month with another 150,000 doses arriving in March and April this year.
FDA’s Secretary-General Dr. Paisan Dankhum said this application was submitted on December 22 with the vaccine to be used in emergency situations. Careful consideration was made on the quality and safety of the Italian-produced vaccine before registration was permitted.
The import licence is for one year and when the vaccine arrives there will be random checks to ensure the quality is as specified by the company.
Where production of AstraZeneca vaccine in Thailand in cooperation with Siam Bioscience Co., Ltd. is concerned, there has to be first the registration of the production site after which it could be used for this purpose from May this year onwards, he added.
In another development the Centre for Covid-19 Situation Administration’s (CCSA’s) spokesman Dr. Taweesilp Visanuyothin got a negative result from a coronavirus test today necessitated by exposure to a National Broadcasting Services of Thailand (NBT) news anchor who in turn had close contact with to another news presenter who had caught the disease.
Top: The AstraZeneca vaccine. Photo: Thai Rath